← Human Trials & Peer-Reviewed Studies
Effect of Zinc Supplementation on Physical and Psychological Symptoms, Biomarkers of Inflammation, Oxidative Stress, and Brain-Derived Neurotrophic Factor in Young Women with Premenstrual Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
Plain-language guide to PMID 31154571 (2020): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 12 women.
Key Facts
- PMID
- 31154571
- Journal
- Biological trace element research
- Year
- 2020
- Study type
- Randomized Controlled Trial
- Authors
- Jafari F et al. (3 authors)
- DOI
- 10.1007/s12011-019-01757-9
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
Data on the effects of zinc supplementation on biomarkers of inflammation, oxidative stress, and antidepressant-like effect among young women with premenstrual syndrome (PMS) are scarce.
This study was a randomized, double-blind, placebo-controlled trial.
Who Took Part
The study group was 12 women.
The age groups tagged for this paper are teenagers, young adults and adults, women only.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
Some women received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
What Was Measured
Topics PubMed links to this paper include Antioxidants, Biomarkers, Brain-Derived Neurotrophic Factor, C-Reactive Protein, Dietary Supplements, Inflammation and Oxidative Stress.
The authors tagged it with the keywords Premenstrual syndrome, Supplementation and Zinc.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 12 women.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2020 (Biological trace element research), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.